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Objective: There has been controversy over whether diffusion–perfusion mismatch pro-
vides a biomarker for the ischemic penumbra. In the context of clinical stroke trials, regions
of the diffusion–perfusion mismatch that do not progress to infarct in the absence of reper-
fusion are considered to represent “benign oligemia.” However, at least in some cases
(particularly large vessel stenosis), some of this hypoperfused tissue may remain dysfunc-
tional for a prolonged period without progressing to infarct and may recover function if
eventually reperfused. We hypothesized that patients with persistent diffusion–perfusion
mismatch using a hypoperfusion threshold of 4–5.9 s delay on time-to-peak (TTP) maps
at least sometimes have persistent cognitive deficits relative to those who show some
reperfusion of this hypoperfused tissue.
Methods: We tested this hypothesis in 38 patients with acute ischemic stroke who had
simple cognitive tests (naming or line cancelation) and MRI with diffusion and perfusion
imaging within 24 h of onset and again within 10 days, most of whom had large vessel
stenosis or occlusion.
Results: A persistent perfusion deficit of 4–5.9 s delay in TTP on follow up MRI was asso-
ciated with a persistent cognitive deficit at that time point (p<0.001). When we evaluated
only patients who did not have infarct growth (n=14), persistent hypoperfusion (persistent
mismatch) was associated with a lack of cognitive improvement compared with those who
had reperfused. The initial volume of hypoperfusion did not correlate with the later infarct
volume (progression to infarct), but change in volume of hypoperfusion correlated with
change in cognitive performance (p=0.0001). Moreover, multivariable regression showed
that the change in volume of hypoperfused tissue of 4–5.9 s delay (p=0.002), and change
in volume of ischemic tissue on diffusion weighted imaging (p=0.02) were independently
associated with change in cognitive function.
Conclusion: Our results provide additional evidence that non-infarcted tissue with a TTP
delay of 4–5.9 s may be associated with persistent deficits, even if it does not always result
in imminent progression to infarct. This tissue may represent the occasional opportunity
to intervene to improve function even days after onset of symptoms.
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INTRODUCTION
At the onset of an ischemic stroke, an occluded blood vessel results
in diminished blood flow to a region of brain tissue, resulting in
cerebral ischemia. Ischemic tissue becomes electrically dysfunc-
tional and can progress to infarction. The term ischemic penumbra
was coined by Astrup and colleagues in the 1970s to characterize a
state of brain tissue in which “neurons remain structurally intact
but functionally inactive” and in which a regional increase in cere-
bral blood flow can restore this activity (1). From experiments in
baboons, they reported dual thresholds for ischemia; the thresh-
old for cell death (signaled by the release of K+) was markedly
lower than the threshold for complete electrical failure of neu-
rons. In its original use, the “penumbra” differentiated the outer
rim, or “half shadow” of tissue, which had reached the threshold
for electrical failure, from the inner core of infarction, which had
reached the threshold for sustained energy failure resulting in ion
pump failure (2). Thus, acute occlusion of a large cerebral artery
typically results in region of diminished blood flow in which the
central core experiences the most severe ischemia and can rapidly
progress to infarct. Surrounding the core there may be a region of
hypoperfusion that is ischemic but not infarcted; this area is com-
monly referred to as the ischemic penumbra. The penumbra is
electrically dysfunctional tissue that, when reperfused, will regain
function.
With the introduction of positron emission tomography (PET)
imaging, regional cerebral blood flow could be measured in
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humans, and the thresholds for ischemia and dysfunction were fur-
ther defined. The concept of ischemic penumbra was elaborated
by Muir and colleagues (3) to include the following criteria: “(a)
hypoperfusion <20 mL/100 g/min; (b) abnormal neuronal func-
tion documented by a correlation with acute clinical deficit; (c)
physiological and/or biochemical characteristics consistent with
cellular dysfunction but not death; (d) uncertain fate; and (e)
salvage of this tissue is correlated with better clinical recovery”
(p. 761). Surrounding the layer of ischemic penumbra (reduced
cerebral blood flow to <20 mL/100 g/min) exhibiting impaired
neural function but preserved tissue integrity, it was recognized
there was often a third zone of reduced blood flow. This zone was
defined as tissue with relatively small reductions in blood flow of
20–50 mL/100 g/min. It was assumed this tissue would maintain
function for a protracted time and would be unlikely to proceed
to infarction, and was thus labeled “benign oligemia.”
With the advent of multimodal MRI, a different biomarker for
the penumbra was proposed (3, 4). Diffusion weighted imaging
(DWI), which measures the movement of water in brain tissue,
was used to delineate ischemic tissue that had sustained energy
failure and thus exhibited diffusion restriction. Perfusion weighted
imaging (PWI), which uses a bolus tracking dynamic scan to mea-
sure the delivery of blood to the brain, was used to delineate the
region of ischemia. Thus, the difference between the DWI lesion
and the PWI lesion was postulated to be a biomarker for the
ischemic penumbra. This biomarker has held up when compared
to biomarkers of penumbra obtained from PET imaging (5–7).
As the field of acute stroke treatment was emerging, it was
postulated that the diffusion–perfusion mismatch would guide
treatment and predict response to therapy. In order to use this
biomarker in such a manner it had to be adapted into a predic-
tive model. Initially, it was hypothesized that in the absence of
acute vessel recanalization, the infarcted core would grow into
the ischemic penumbra and the opportunity for clinical recovery
would be lost. This hypothesis has been the driving force behind
most MRI-guided acute stroke research.
In the context of the MRI-guided therapies, the term “penum-
bra”has now come to be understood as“tissue at risk.”A number of
authors have pointed out that the diffusion–perfusion mismatch
includes both hypoperfused tissue that will imminently infarct
(“tissue at risk”) and hypoperfused tissue that will survive despite
hypoperfusion (“benign oligemia”) (8). In the context of MRI-
guided therapies, benign oligemia is thought to be irrelevant, and
it is excluded from the lesion targeted for reperfusion therapy.
It has been shown that MRI based thresholds of hypoperfu-
sion are capable of separating benign oligemia from tissue that is
at-risk of imminent infarction. The threshold for distinguishing
benign oligemia from tissue at risk has varied across studies and
changed over time; however, the most frequently used threshold in
the current literature is a time-to-maximum of 6 s (9). However,
there might be tissue in between tissue at risk for imminent pro-
gression to infarct and benign oligemia – tissue that will remain
dysfunctional if blood flow remains compromised and will regain
function if blood flow is restored. A number of case reports of
improvement in function after reperfusion by carotid endarterec-
tomy, carotid stenting, or blood pressure elevation even days after
stroke onset indicate the existence of this tissue that exists in a state
of limbo between adequate blood flow for function and immediate
risk of infarction (10–12). It is not entirely clear how this dysfunc-
tional tissue survives over days with “misery perfusion”; it may
do so by collateral blood flow or intermittent blood flow from the
main arterial supply. Nevertheless, MRI might be able to define the
thresholds of this hypoperfused, dysfunctional tissue. Data from
the case reports of reversible function days after stroke indicate that
a delay in time-to-peak (TTP) arrival of contrast of 4–5.9 s might
represent tissue that is dysfunctional but not always at immedi-
ate risk of progression to infarction (particularly in cases of large
vessel stenosis). This segment of penumbral tissue is important
to define, as it may represent an opportunity to improve at least
cortical function in special cases long after the typical window for
reperfusion therapies.
A study using PET as the gold standard found that a TTP thresh-
old of 4.2 s (or Tmax threshold of 5.2 s) corresponds to penumbra
as operationally defined above (see definition by Muir and col-
leagues), and indicated that the TTP threshold might be a more
stable (3, 5). Another study found that non-deconvolved TTP out-
performed Tmax in distinguishing oligemia from tissue at risk
(13), and using local arterial input functions did not improve
the predictive performance of the algorithms over conventional
methods. Other studies have shown that reperfusion of penum-
bral tissue identified on MRI results in not only tissue salvage but
also improved outcomes (14). However, the clinical relevance of a
persistent hypoperfusion in the range of TTP of 4–5.9 s delay has
not been adequately addressed.
As noted, a few studies have shown that individuals with per-
sistent hypoperfused tissue of 4–5.9 s delay in TTP have shown
improved function with reperfusion (10–12). Thus, these studies
illustrate that the diffusion–perfusion mismatch defined by MRI
can reveal penumbra as originally described by Astrup and col-
leagues in primates – marginally perfused, dysfunctional tissue
that can regain function if reperfused (3). These results mirror
results of other studies showing improvement in function with
reperfusion of penumbra defined by PET or CT perfusion (15–
19). What these previous studies did not do, however, was show
that persistent diffusion–perfusion mismatch, defined by hypop-
erfusion thresholds of 4–5.9 s delay in TTP, was associated with
persistent dysfunction. Tissue within this range of TTP is often
considered to be within the “benign oligemia” range, because it
does not always progress to infarct. Persistent hypoperfused tissue
of 4–5.9 s delay in TTP beyond the infarct that is associated with
persistent deficits, in the absence of infarct growth, would provide
evidence that hypoperfused tissue of 4–5.9 s delay in TTP may not
be so benign.
Here, we address the question, “Is benign oligemia really
benign?” We hypothesized that patients with a persistent
diffusion–perfusion mismatch defined using upper and lower
hypoperfusion thresholds of TTP 4–5.9 s delay have persistent dys-
functional tissue and poorer performance on cognitive tests when
compared with patients who have reperfused, whether or not there
is growth of the infarct. We studied this hypothesis by evaluating
changes in volumes of infarct and hypoperfusion in a cohort of
patients who underwent serial imaging and cognitive testing over
several days during hospitalization for an acute ischemic stroke.
Most of these patients had large vessel stenosis or occlusion, which
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carries the greatest risk for persistence of a diffusion–perfusion
mismatch.
MATERIALS AND METHODS
Subjects were identified from a database of acute ischemic stroke
patients who had been recruited from the inpatient stroke service
under an IRB approved protocol to undergo serial cognitive and
MRI testing, utilizing the following criteria: (1) clinical diagno-
sis of unilateral anterior circulation stroke, (2) cognitive testing
and MRI scan performed within 24 h at two time points within
10 days, and (3) adequate quality DWI and PWI images for volu-
metric analysis at both time points. Patients had a variety of acute
stroke interventions, often attempts to restore perfusion, includ-
ing induced blood pressure elevation, carotid stenting, urgent
endarterectomy, and intraarterial thrombolysis, at the discretion
of the primary clinical team.
Cognitive testing consisted of a picture naming task for left
hemisphere strokes and a line cancelation test for right hemisphere
strokes both of which were scored as a percent error. The line can-
celation test usually requires <2 min to administer. The picture
naming test usually requires <10 min to administer. These tests
are described in previous papers (14). For both, 10% error rate
represents >3 SD from mean for normal controls (14).
Volumes of ischemia on DWI were calculated by manual delin-
eation of a region of interest (ROI) that was bright on DWI and
dark on apparent diffusion coefficient (ADC) maps. Volumes of
hypoperfusion on PWI were calculated by manually segmenting
thresholded TTP maps. We calculated volumes of tissue with delay
in TTP of 4–5.9 and ≥6 s delay relative to normal tissue (the
homologous voxels in the contralateral hemisphere). Perfusion
source images were exported as a DICOM time series using OsiriX
software. Then, TTP maps were generated and analyzed by ImageJ
software1 by a technician blinded to cognitive test scores. TTP
maps were calculated in seconds beyond normal using the homol-
ogous region in the unaffected hemisphere as a reference. TTP
maps were used instead of Tmax maps as they have been shown to
be as effective in detecting perfusion abnormalities and are simple
and reproducible (5). We chose two separate thresholds to deter-
mine the volume of tissue with 4–5.9 s delay in TTP (tissue we
hypothesized to be potentially viable, but dysfunctional), and tis-
sue with≥6 s delay in TTP (tissue more likely to be at immediately
risk to progress to infarct).
Lack of reperfusion was defined as a <10% reduction in the
PWI lesion volume. Infarct growth was defined as a>10% increase
in DWI lesion volume. We chose these small thresholds of volume
change in order to evaluate the effects of failure to reperfuse, in
the absence of infarct growth (i.e., the persistence of diffusion–
perfusion mismatch, using thresholds of hypoperfusion of TTP
delay 4–5.9 or ≥6 s). Some treatment studies define “reperfusion”
as>50% (or greater) reduction in PWI volume (14, 20). However,
in our study we did not want patients with partial reperfusion, who
may also have partial improvement, to contaminate the effect of
sustained diffusion–perfusion mismatch, which is the target pop-
ulation for this study. Therefore, relatively strict definitions for
lack of reperfusion and infarct growth were used.
1http://imagej.nih.gov/
We first tested the hypothesis that patients who showed no
reperfusion of tissue with 4–5.9 s delay in TTP would show less
change in cognitive score than patients who showed reperfusion,
irrespective of infarct growth, using a t -test in the Stata 13.1 soft-
ware package2 to compare the two groups. Patients were separated
into two groups based on whether or not they experienced infarct
growth, defined as an increase of 10% in the DWI lesion vol-
ume from the first time point to the second time point. These
two groups were each further divided based on whether there was
reperfusion – defined as a 10% reduction in volume of hypoper-
fusion on PWI from the first to the second time point (Figure 1).
Patients with neither reperfusion nor infarct growth were con-
sidered to be the best example of persistent diffusion–perfusion
mismatch with PWI threshold of 4–5.9 s delay in TTP. Changes
in cognitive scores were compared between the two subgroups
(reperfusion vs. persistent hypoperfusion) with t -tests.
We also evaluated the Pearson correlation between baseline vol-
ume of hypoperfusion (using 4–5.9 s delay in TTP) and (1) final
infarct volume measured by volume of ischemia on the second
DWI, and (2) persistent hypoperfusion measured by volume of
hypoperfusion measured on the second PWI. We also evaluated
the Pearson correlation between change in cognitive score and
change in volume of hypoperfusion using 4–5.9 s delay in TTP, to
test the hypothesis that change in hypoperfusion reflects change in
cortical function. However, it is not assumed that there is a direct
relationship between the cognitive test score and the change in
volume since location of reperfusion likely also plays a significant
role. Finally, to determine if the change in volume of hypoperfused
tissue contributed to cognitive change independently of change in
infarct volume, we carried out a multivariable linear regression
analysis, with cognitive change as the dependent variable, and
changes in volumes of ischemia on DWI and hypoperfusion on
2http://www.stata.com/
FIGURE 1 | Schematic of study design: outer circle represents brain;
middle circle represents volume of hypoperfusion on PWI; inner circle
represents volume of ischemia on DWI.
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Intracranial stenoisis/occlusion (n=21) 1 14 6
Extracranial ICA stenosis (n=2) 2
Acute ICA occlusion or dissection (n=2) 2
Watershed post CABG (n=1) 1
Cardioembolic (n=6) 6
Hypercoagulable state (cancer) (n=2) 1 1
Uncertain etiology (OCP, PFO) (n=2) 2
Small vessel disease (n=2) 2
apressors, midodrine, and/or fludrocortisone.
ICA, internal carotid stenosis; CABG, coronary artery bypass graft; OCP, oral contraceptive pills; PFO, patent foramen ovale.
PWI (with thresholds of 4–5.9 and≥6 s delay) as the independent
variables.
RESULTS
Of the 38 patients identified from the database who met the inclu-
sion criteria, 45% were women; mean age was 61 years. There were
29 patients with a left hemisphere stroke and 9 with a right hemi-
sphere stroke. Table 1 summarizes their etiology and recorded
treatment based on retrospective review of their medical records.
The mean volume of ischemia on initial DWI was 20.0 cc (range
0–140.4 cc); mean volume of hypoperfusion on initial PWI was
26.8 cc (range 0–111.8 cc) using a threshold of 4–5.9 s TTP, and
mean 25.3 (0–116.5 cc) using a threshold of ≥6 s TTP. Mean base-
line National Institutes of Health Stroke Scale Score was 6.5 (range
0–24). The mean baseline error rate on the naming test was 57.9%
errors (range 0–100% errors). Mean baseline error rate on the
cancelation (neglect) test was 43.2% (0–99% errors).
We first evaluated the change in cognitive test error rate for
those who failed to reperfuse (had a persistent diffusion–perfusion
mismatch; n= 15) compared to those who reperfused (n= 23)
in the entire group of patients (irrespective of infarct growth).
Using a 10% reduction in perfusion abnormality with a threshold
of 4–5.9 s delay on TTP maps, there was a significant difference
in the change in error rates on cognitive testing between those
who failed to reperfuse (mean 3% increase in error rate) vs. those
who did reperfuse [mean 40% decrease in error rate, t (36)= 4.1,
p= 0.0001]. Using a 10% reduction in perfusion abnormality with
a threshold of 6 s delay on TTP maps, there was also a significant
difference in the change of error rates on cognitive testing, with
an increase in errors for those without reperfusion compared to a
decrease in error rates for those who did reperfuse [mean 14 vs.
−34; t (36)= 3.99; p= 0.0003].
Of the 14 patients without infarct growth, the diffusion–
perfusion mismatch persisted in 8 (57%) patients who had a mean
separation between MRI scans of 3.9 days. Comparing patients
with persistent diffusion–perfusion mismatch with those who had
reperfused revealed significantly less change in cognitive impair-
ment in those with persistent functional diffusion–perfusion mis-
match [−5 vs.−40%; t (12)= 2.4; p= 0.02]. Examples of patients
FIGURE 2 | Example of patient who showed growth of infarct of >10%
with <10% reperfusion and persistent severe left neglect on line
cancelation task (85 and 71% errors, 3 days later). The color key shows
the relative delay in TTP (each color corresponds to 2 s delay in TTP arrival of
contrast).
in each group are shown in Figures 2–5. Figure 6 shows a boxplot
of the change in error rates for patients in each of the four groups
based on PWI and DWI change. When evaluating the difference
between change in cognitive score between those with persistent
diffusion–perfusion mismatch when based on a TTP threshold of
6 s instead of 4–5.9 s, the relationship between persistent cogni-
tive deficit and persistent diffusion–perfusion mismatch was not
significant but showed the same trend [−2 vs.−34%; t (12)= 1.9;
p= 0.075].
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FIGURE 3 | Example of patient who showed growth of infarct >10%
with reperfusion >10% reperfusion with recovery from left neglect on
the line cancelation task (99–0% errors, 4 days later). The color key
shows the relative delay in TTP (each color corresponds to 2 s delay in TTP
arrival of contrast).
Infarct growth was present in 24 (63%) patients. Even among
these patients, many had persistent diffusion–perfusion mismatch
(see Figures 3 and 6). Those who failed to reperfuse showed
an increase in error rate, while those who reperfused showed a
decrease in error rate; the difference was significant, both using
a threshold of 4–5.9 s delay in TTP [8 vs. −39%; t (22)= 3.3;
p= 0.002] and using a threshold of 6 s delay in TTP [26 vs.−34%;
t (12)= 3.6; p= 0.002].
There was a reduction in DWI lesion volume in eight patients;
seven of these patients also showed a >10% reduction in volume
of hypoperfusion with 4–5.9 s delay, and associated reduction in
errors on cognitive testing. One patient who showed a decrease
in DWI lesion showed an increase in volume of hypoperfusion on
PWI, and an increase in error rate on cognitive testing.
For the patients in this study, the initial volume of hypop-
erfusion with 4–5.9 s TTP delay did not correlate with the final
infarct size (r = 0.051; p= 0.76). However, the initial volume of
hypoperfusion did correlate with the final volume of hypoper-
fusion (r = 0.53; p= 0.0006). Moreover, the change in volume
of hypoperfusion with 4–5.9 s delay in TTP correlated with the
change in cognitive score (r = 0.58; p= 0.0001) (Figure 7). We
merged the scores for naming error rate (left hemisphere stroke)
and neglect error rate (right hemisphere stroke) for this analy-
sis, which seemed reasonable, as the scores were comparable in
FIGURE 4 | Example of patient who showed no growth infarct (<10%)
with <10 reperfusion and persistent severe naming impairment (100
and 100% errors, 4 days later). The color key shows the relative delay in
TTP (each color corresponds to 2 s delay in TTP arrival of contrast).
capturing variability: the mean change in naming error rate was
−22.8 (±SD 39.3). The mean change in neglect error rate was
−22.6 (±SD 30.8).
Finally, to determine if change in volume of hypoperfu-
sion was associated with change in cognitive function indepen-
dently of change in volume of ischemia on DWI, we carried
out a multivariable regression analysis. We found that both
change in volume of hypoperfusion with TTP delay of 4–5.9 s
(β= 0.542; p= 0.002) and change in volume of ischemia on DWI
(β=−0.314; p= 0.023) independently contributed to change in
error rate on cognitive testing (in opposite directions). Together,
these two variables accounted for 43% of the variance in change
in cognitive score (r2= 0.43; p= 0.0001). Change in volume of
hypoperfusion with ≥6 s delay in TTP was not independently
associated with change in cognitive score.
DISCUSSION
Restoration of blood flow is the goal of all acute ischemic stroke
treatments. Preventing infarct and tissue death is a logical target
for acute intervention. Previous studies have shown that imaging
(PET or MRI) can identify this tissue at risk. However, focusing
only on tissue at risk for imminent progression to infarct carries
the potential risk of ignoring subacute brain ischemia that might
persist beyond the initial event. In this study, we demonstrated that
the diffusion–perfusion mismatch with hypoperfusion thresholds
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FIGURE 5 | Example of patient who showed no growth infarct (<10%)
with >10 reperfusion with improvement in naming performance to
normal performance (23 and 10% errors, 4 days later). The color key
shows the relative delay in TTP (each color corresponds to 2 s delay in TTP
arrival of contrast).
of 4–5.9 s delay in TTP can sometimes persist for days and seems
to result in persistent cognitive deficits. Those who failed to reper-
fuse this tissue failed to improve in cognition; while those who
reperfused did improve (p< 0.001).
In our study, “benign oligemia” defined as tissue with 4–5.9 s
delay in TTP was not always benign. Rather, at least some of this
tissue seemed to represent “misery perfusion” described by Baron
in 1981, which can show functional recovery if reperfused (15).
The persistence of perfusion deficits in this range was associated
with persistent cognitive deficits when compared with those who
reperfused. We confirmed that the initial volume of hypoperfu-
sion with TTP 4–5.9 s delay in TTP did not predict final infarct
volume, but did correlate with final volume of hypoperfusion. Fur-
thermore, change in volume of TTP delay correlated with change
in cortical dysfunction (measured by change in cognitive score).
These results are also consistent with the proposal that tissue with
this degree of hypoperfusion (4–5.9 s delay) measured with PWI
represents reversibly dysfunctional tissue, even if it is not always
at imminent risk for progression to infarct. On the other hand,
tissue with TTP delay of ≥6 s TTP delay was not associated with
change in cognitive function, independently of change in volume
of ischemia of DWI and change in volume of hypoperfusion with
4–5.9 s delay. Tissue with ≥6 s TTP delay likely includes much
more tissue that is not reversible days after stroke.
There were several limitations to this study. This is a retro-
spective analysis of prospectively collected data collected over a
few years. The MRI scan parameters were not standardized and
varied considerably with regard to pulse sequences and magnet
strength. The scans at the two time points were not registered, as
no high-resolution anatomical scan was obtained with these clini-
cal scans. We were also not able to register the DWI to the PWI on
voxel-by-voxel basis; therefore, hypoperfusion defined as 4–5.9 s
delay in TTP may have also included some core infarct. However,
it is unlikely that the hypoperfused tissue defined with these dual
thresholds included much core infarct, because reperfusion of the
tissue with 4–5.9 s TTP delay (reduction in that volume) was asso-
ciated with improvement in cognitive function, independently of
change in infarct volume. Cognitive testing may be cumbersome
when time is of essence in treatment of acute stroke. However, the
simple cognitive tests we used here take <10 min to administer.
We also note that these patients were not typical stroke patients.
They had a second MRI scan that included PWI 2–10 days after the
first. This second scan was generally obtained because persistent
hypoperfusion was suspected or to evaluate the effectiveness of
intervention to improve perfusion or collateral blood flow (such
as temporary induced blood pressure elevation). Thus, there was a
relatively small percentage of lacunar strokes, and a relatively large
percentage of large vessel stenosis, as the etiology of stroke.
We do not wish to claim that the rate of persistent diffusion–
perfusion mismatch observed in this study is representative for
an acute stroke population. Rather, our goal was to demonstrate
that diffusion–perfusion mismatch with a hypoperfusion thresh-
old of 4–5.9 s delay in TTP can sometimes persist, and appears to
represent dysfunctional tissue that can recover function if blood
flow is restored. As noted, is not clear how this tissue sometimes
survives days after onset – perhaps by misery perfusion from the
main arterial supply, or from collateral circulation, either of which
may fluctuate with any variable that changes the mean arterial
pressure or intracranial pressure (body position, respiratory rate,
temperature, and so on). A relatively small number of patients
with persistent hypoperfusion of 4–5.9 s delay in TTP showed
some infarct growth, indicating that the area of hypoperfusion
included some “tissue-at-risk” as well as “benign oligemia.”
Future studies should address some of the limitations of this
study, by evaluating both the fate and the clinical consequences of
voxels that that are initially non-infarcted (using a specific ADC
threshold) but hypoperfused (using various TTP ranges, e.g., 2–3,
3–4, 4–5 s). This analysis should be done on a large, unselected
series of acute ischemic stroke patients, using serial imaging regis-
tered to high resolution anatomical images, so that DWI and PWI
can be registered to each other at each time point and across time
points.
Despite its limitations our study indicates that symptomatic,
reversible perfusion deficits can be identified by diffusion–
perfusion mismatch using a hypoperfusion threshold of 4–5.9 s
TTP delay and can occasionally persist for days without pro-
gressing to infarction. Thus, the diffusion–perfusion mismatch
defined in this way may be clinically useful for identifying patients
who might still benefit from reperfusion (e.g., urgent carotid
endarterectomy, stenting, efforts to increase collateral blood flow).
Failure to restore blood flow to tissue with a TTP delay of 4–5.9 s
Frontiers in Neurology | Stroke January 2015 | Volume 5 | Article 280 | 6
Motta et al. Cognitive improvement with mismatch reperfusion
FIGURE 6 | Boxplot of the change in cognitive score (i.e., change in error rate – negative values indicate improved cognition) for each of four groups
defined by change on DWI and PWI.
FIGURE 7 | Correlation between change in cognitive score and change
in volume of hypoperfusion (defined asTTP delay of 4–5.9 s).
seems to result in persistent deficits in some cases even if it does
not result in imminent progression to infarct. These results do not
detract from the usefulness of the diffusion–perfusion mismatch
model (or other models of the penumbra) for identifying tissue at
risk and patients who require acute intervention, but provide yet
another way this imaging might be useful in clinical care.
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